AusperBio Announces Phase 2 Clinical Data for Hepatitis B Oligonucleotide Therapy AHB-137
May 27, 2026 15:47
CST Updated
18:14
AusperBio
Biological Vaccine and Nucleic Acid Drug Developer
Biological Vaccine and Nucleic Acid Drug Developer